质子泵抑制剂的过度处方
Overprescribing proton pump inhibitors.
作者信息
Forgacs Ian, Loganayagam Aathavan
出版信息
BMJ. 2008 Jan 5;336(7634):2-3. doi: 10.1136/bmj.39406.449456.BE.
Abstract
Is expensive and not evidence based
摘要
价格昂贵且缺乏循证依据
相似文献
1
Overprescribing proton pump inhibitors.质子泵抑制剂的过度处方
BMJ. 2008 Jan 5;336(7634):2-3. doi: 10.1136/bmj.39406.449456.BE.
2
Missing PPI prescriptions while overprescribing?在过度开药的同时却遗漏了质子泵抑制剂（PPI）处方？
Eur J Clin Pharmacol. 2023 Nov;79(11):1579-1581. doi: 10.1007/s00228-023-03564-7. Epub 2023 Sep 19.
3
General Practice Research Database for prescribing analysis.用于处方分析的全科医学研究数据库。
Lancet. 1998 Feb 7;351(9100):453-4. doi: 10.1016/S0140-6736(05)78411-7.
4
Proton pump inhibitors: why this gap between guidelines and prescribing practices in geriatrics?质子泵抑制剂：老年医学指南与处方实践之间为何存在这种差距？
Eur J Clin Pharmacol. 2019 Sep;75(9):1327-1329. doi: 10.1007/s00228-019-02692-3. Epub 2019 May 25.
5
Prescribing PPIs.开具质子泵抑制剂处方。
Drug Ther Bull. 2017 Oct;55(10):117-120. doi: 10.1136/dtb.2017.10.0541.
6
Overprescribing PPIs: An old problem.质子泵抑制剂的过度处方：一个老问题。
BMJ. 2008 Jan 19;336(7636):109. doi: 10.1136/bmj.39458.462338.3A.
7
[Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?].[内科病房住院患者质子泵抑制剂处方调查：对法国指南的依从性如何？]
Rev Med Interne. 2015 Oct;36(10):651-7. doi: 10.1016/j.revmed.2015.04.014. Epub 2015 Jun 4.
8
Putting proton pump inhibitors into perspective.正确看待质子泵抑制剂。
Geriatr Nurs. 2017 Nov-Dec;38(6):589-590. doi: 10.1016/j.gerinurse.2017.10.006. Epub 2017 Nov 11.
9
[Practices evaluation of prescription of proton pump inhibitors in pharmacy].[药房质子泵抑制剂处方实践评估]
Therapie. 2019 Dec;74(6):682-685. doi: 10.1016/j.therap.2019.04.004. Epub 2019 Apr 13.
10
[Validity of proton pump inhibitors' prescriptions in a department of internal medicine].[内科某科室质子泵抑制剂处方的有效性]
Rev Med Interne. 2007 Feb;28(2):86-93. doi: 10.1016/j.revmed.2006.09.030. Epub 2006 Oct 20.
引用本文的文献
1
Artificial intelligence-assisted quality control circles led by clinical pharmacists to improve the rational use of parenteral proton pump inhibitors among hospitalised patients.由临床药师牵头的人工智能辅助质量控制圈，以提高住院患者肠外质子泵抑制剂的合理使用。
Sci Rep. 2025 Aug 26;15(1):31391. doi: 10.1038/s41598-025-16934-1.
2
Proton Pump Inhibitor Use and Risk of Clostridioides difficile Infection: An Umbrella Review of 11 Meta-Analyses.质子泵抑制剂的使用与艰难梭菌感染风险：对11项荟萃分析的综合评价
Cureus. 2025 Jul 6;17(7):e87383. doi: 10.7759/cureus.87383. eCollection 2025 Jul.
3
Factors associated with drug-drug interactions involving citalopram in the UK Biobank.英国生物银行中与涉及西酞普兰的药物相互作用相关的因素。
BJPsych Open. 2025 Aug 1;11(5):e166. doi: 10.1192/bjo.2025.10060.
4
Perceived risk of gastric cancer associated with long-term use of proton pump inhibitors: Bridging the gap.长期使用质子泵抑制剂与胃癌的感知风险：弥合差距。
World J Clin Oncol. 2025 Jul 24;16(7):107091. doi: 10.5306/wjco.v16.i7.107091.
5
Association between preoperative proton pump inhibitor use and postoperative infectious and renal complications following major elective surgery.择期大手术后术前使用质子泵抑制剂与术后感染及肾脏并发症之间的关联。
Can J Surg. 2025 Jul 15;68(4):E305-E312. doi: 10.1503/cjs.010224. Print 2025 Jul-Aug.
6
Bone health, renal outcomes, and iron deficiency anaemia in proton pump inhibitor versus histamine-2 receptor antagonist users: a retrospective cohort study based on TriNetX global collaborative network data.质子泵抑制剂与组胺-2受体拮抗剂使用者的骨骼健康、肾脏结局及缺铁性贫血：一项基于TriNetX全球合作网络数据的回顾性队列研究
BMJ Open Gastroenterol. 2025 Jul 13;12(1):e001723. doi: 10.1136/bmjgast-2024-001723.
7
Appropriate Use of Proton Pump Inhibitors in General Out Patient Department of a Tertiary Care Center of Kathmandu Valley: An Observational Study.加德满都谷地一家三级护理中心普通门诊部质子泵抑制剂的合理使用：一项观察性研究
JNMA J Nepal Med Assoc. 2025 Mar;63(283):149-153. doi: 10.31729/jnma.8913. Epub 2025 Mar 31.
8
Trends in Proton-Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015-2023.丹麦成年人使用质子泵抑制剂的趋势：一项2015 - 2023年的全国性药物使用研究
Basic Clin Pharmacol Toxicol. 2025 Jun;137(1):e70057. doi: 10.1111/bcpt.70057.
9
Proton Pump Inhibitor Use Exceeding the U.S. Food and Drug Administration Approved Treatment Duration for Patients With Peptic Ulcer Disease: A Retrospective Cohort Study.质子泵抑制剂用于消化性溃疡疾病患者超过美国食品药品监督管理局批准的治疗时长：一项回顾性队列研究。
Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70152. doi: 10.1002/pds.70152.
10
Proton pump inhibitors and 1-year risk of adverse outcomes after discharge from internal medicine wards: an observational study in the REPOSI cohort.质子泵抑制剂与内科病房出院后不良结局的1年风险：REPOSI队列中的一项观察性研究
Intern Emerg Med. 2025 Apr 6. doi: 10.1007/s11739-025-03937-z.
本文引用的文献
1
Inappropriate prescribing of proton pump inhibitors in primary care.基层医疗中质子泵抑制剂的不适当处方
Postgrad Med J. 2007 Jan;83(975):66-8. doi: 10.1136/pgmj.2006.051151.
2
Long-term proton pump inhibitor therapy and risk of hip fracture.长期质子泵抑制剂治疗与髋部骨折风险
JAMA. 2006 Dec 27;296(24):2947-53. doi: 10.1001/jama.296.24.2947.
3
Continuation of proton pump inhibitors from hospital to community.质子泵抑制剂从医院到社区的延续使用。
Pharm World Sci. 2006 Aug;28(4):189-93. doi: 10.1007/s11096-006-9028-4. Epub 2006 Oct 26.
4
Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.长期接受质子泵抑制剂治疗患者的停药研究：一项双盲、安慰剂对照试验
Aliment Pharmacol Ther. 2006 Sep 15;24(6):945-54. doi: 10.1111/j.1365-2036.2006.03084.x.
5
Acid suppressive therapy use on an inpatient internal medicine service.住院内科服务中酸抑制疗法的使用。
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1261-6. doi: 10.1345/aph.1G703. Epub 2006 Jun 27.
6
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.使用胃酸抑制剂与社区获得性艰难梭菌相关疾病的风险
JAMA. 2005 Dec 21;294(23):2989-95. doi: 10.1001/jama.294.23.2989.
7
Proton pump inhibitors: a survey of prescribing in an Irish general hospital.质子泵抑制剂：爱尔兰一家综合医院的处方调查
Int J Clin Pract. 2005 Jan;59(1):31-4. doi: 10.1111/j.1742-1241.2004.00298.x.
8
An evaluation of the use of proton pump inhibitors.质子泵抑制剂的使用评估。
Pharm World Sci. 2001 Jun;23(3):116-7. doi: 10.1023/a:1011278030001.
9
Overuse of proton pump inhibitors.质子泵抑制剂的过度使用。
J Clin Pharm Ther. 2000 Oct;25(5):333-40. doi: 10.1046/j.1365-2710.2000.00312.x.
Zotero 插件